InvestorsHub Logo
Followers 0
Posts 54
Boards Moderated 0
Alias Born 02/23/2018

Re: None

Wednesday, 03/14/2018 11:53:31 AM

Wednesday, March 14, 2018 11:53:31 AM

Post# of 27676
Rich Pharmaceuticals' Study Drug RP-323 (TPA) is a Potential Therapeutic Agent for the Treatment of Hodgkin's Lymphoma
Today 9:45 AM ET (GlobeNewswire)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.